存在黏附缺陷和细胞毒性功能降低的自然杀伤细胞与多发性骨髓瘤不良预后相关
研究对10例多发性骨髓瘤(MM)患者和10例年龄/性别匹配的健康供者进行单细胞RNA测序,发现患者骨髓和外周血中成熟细胞毒性CD56dim自然杀伤(NK)细胞亚群频率降低,而表达NF-κB和干扰素-I炎症特征的晚期NK细胞亚群增多;这些NK细胞CD16和CD226低表达、细胞毒性功能差、黏附缺陷。回顾性分析IFM 2009试验177例MM患者骨髓浸润NK细胞,发现NK细胞高频率及CD16和CD226低表达与较短总生存期相关。
要点
- MM患者骨髓和外周血中成熟细胞毒性CD56dim NK细胞亚群频率降低,晚期炎症性NK细胞亚群增多。
- MM中积聚的CD16/CD226低表达NK细胞细胞毒性功能差,并存在LFA-1整合素活化和肌动蛋白聚合降低的黏附缺陷。
- IFM 2009试验177例MM患者中,骨髓NK细胞高频率及CD16和CD226低表达与较短总生存期相关。
核心结论
- CD16/CD226低表达且效应功能降低的NK细胞随MM进展而积聚,并对患者临床结局产生不良影响。
- 作者认为,对MM相关NK细胞功能障碍的深入了解将促进更有效的MM免疫治疗药物的开发。
研究设计与样本
- 对10例MM患者和10例年龄/性别匹配的健康供者进行NK细胞单细胞RNA测序分析,覆盖骨髓和外周血。
- 对来自Intergroupe Francophone du Myélome(IFM)2009试验的177例MM患者回顾性队列进行骨髓浸润NK细胞分析。
主要发现
- MM患者中成熟细胞毒性CD56dim NK细胞亚群频率降低,表达NF-κB和干扰素-I炎症特征的晚期NK细胞亚群频率增高。
- MM中积聚的NK细胞亚群CD16和CD226表达低,细胞毒性功能差。
- MM CD16/CD226低表达NK细胞存在黏附缺陷,表现为淋巴细胞功能相关抗原1(LFA-1)整合素活化降低和肌动蛋白聚合减少,可能解释其体外效应功能受限。
- IFM 2009试验177例MM患者中,NK细胞高频率及其CD16和CD226低表达与较短总生存期相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The promising results obtained with immunotherapeutic approaches for multiple myeloma (MM) call for a better stratification of patients based on immune components. The most pressing being cytotoxic lymphocytes such as natural killer (NK) cells that are mandatory for MM surveillance and therapy. Here, we performed a single-cell RNA sequencing analysis of NK cells from 10 patients with MM and 10 age/sex-matched healthy donors that revealed important transcriptomic changes in the NK cell landscape affecting both the bone marrow (BM) and peripheral blood compartment. The frequency of mature cytotoxic CD56dim NK cell subsets was reduced in patients with MM at the advantage of late-stage NK cell subsets expressing NF-κB and interferon-I inflammatory signatures. These NK cell subsets accumulating in patients with MM were characterized by low CD16 and CD226 expression and poor cytotoxic functions. MM CD16/CD226Lo NK cells also had adhesion defects with reduced lymphocyte function-associated antigen 1 (LFA-1) integrin activation and actin polymerization that may account for their limited effector functions in vitro. Finally, analysis of BM-infiltrating NK cells in a retrospective cohort of 177 patients with MM from the Intergroupe Francophone du Myélome (IFM) 2009 trial demonstrated that a high frequency of NK cells and their low CD16 and CD226 expression were associated with a shorter overall survival. Thus, CD16/CD226Lo NK cells with reduced effector functions accumulate along MM development and negatively affect patients' clinical outcomes. Given the growing interest in harnessing NK cells to treat myeloma, this improved knowledge around MM-associated NK cell dysfunction will stimulate the development of more efficient immunotherapeutic drugs against MM.
引用
- Blanquart E, Ekren R, Rigaud B, et al. NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma. Blood. 2024. PMID: 38875515. doi:10.1182/blood.2023023529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。